
BRONX, N.Y., Dec. 2 (UPI) -- An artificial blood product reportedly shows promise in clinical trials in Stockholm, the first time a blood substitute has been used successfully in humans.
The substance was developed at the Albert Einstein College of Medicine of Yeshiva University, supported by $2.2 million in grants from the National Institutes of Health and the U.S. Army.
A powdered version of the substitute that can be reconstituted as needed with the simple addition of water is also in development.
One researcher told the BBC: "If this really works all the way, then mankind will have taken a big step forward."
Dr. Seetharama Acharya led the Einstein research. Using donated blood, which generally has a shelf-life of 42 days, Acharya developed a technology making the hemoglobin removed from "old" red blood cells suitable for use in transfusions.
"With our blood product, the issue of blood typing is removed," Acharya said.
"When time is of the essence -- on the battlefield, for example -- being able to provide a blood transfusion without the need for typing can save critical seconds," said Dr. Joel Friedman, professor of biophysics and physiology at Einstein.
|
|
|
|
|
|
| Additional Science News Stories | |
WASHINGTON, May 31 (UPI) --
The U.S. House Thursday rejected a bill that would outlaw abortions based on gender, with abortion opponents promising to make the vote an election issue.
|
The latest news on today's hottest celebrities ...
|
BALTIMORE, May 31 (UPI) --
U.S. astronomers are forecasting the Milky Way will have a violent collision with the neighboring Andromeda galaxy in about 4 billion years.
|
CLEVELAND, May 31 (UPI) --
Cleveland prosecutors have dropped their case against a man who was ticketed for littering when he dropped a dollar he was attempting to give a disabled person.
|
| Stories | Photos | People | Comments |
View Caption